×
AbbVie Basic EPS 2012-2026 | ABBV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
AbbVie basic eps for the twelve months ending March 31, 2026 was
$0.62
, a
73.62% decline
year-over-year.
AbbVie annual basic eps for 2025 was
$0B
, a
100% decline
from 2024.
AbbVie annual basic eps for 2024 was
$0.002B
, a
12.09% decline
from 2023.
AbbVie annual basic eps for 2023 was
$0.003B
, a
58.95% decline
from 2022.
View More
AbbVie Basic EPS 2012-2026 | ABBV
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
AbbVie annual basic eps for 2025 was
$0B
, a
100% decline
from 2024.
AbbVie annual basic eps for 2024 was
$0.002B
, a
12.09% decline
from 2023.
AbbVie annual basic eps for 2023 was
$0.003B
, a
58.95% decline
from 2022.
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$887.6B
Johnson & Johnson (JNJ)
$574.4B
Roche Holding AG (RHHBY)
$318.8B
Merck (MRK)
$299.9B
Novartis AG (NVS)
$294B
Novo Nordisk (NVO)
$167.5B
Pfizer (PFE)
$153.1B
Sanofi (SNY)
$114B
Bayer (BAYRY)
$46.2B
Innoviva (INVA)
$1.8B